Publications by authors named "Yuriko Ishikawa"

Claim this Profile
M
Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection.
Ryo Akazawa, Takashi Mikami, Masaki Yamada, Itaru Kato, Hirohito Kubota, Yuriko Ishikawa

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of bullous pemphigoid after nemolizumab administration.
Yuriko Ishikawa, Ken Washio

J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global-SHANEL Asia model predicting chemical concentration in rivers with high spatio-temporal resolution, suitable for climate change scenarios.
Masayuki Yamane, Hiroshi Honda, Michihiro Murata, Tomoya Kawaguchi, Yuriko Ishikawa

J Environ Manage· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of fixed drug eruption caused by allylisopropylacetylurea and bromovalerylurea in the same lesion.
Yuriko Ishikawa, Kanako Akashi, Saki Ueda, Ken Washio

Contact Dermatitis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the effect of improved sewage disposal rates on ecological status for aquatic organisms in Japan.
Toyohiko Nakakubo, Midori Kawabata, Yuriko Ishikawa, Yuichi Iwasaki

Heliyon· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Detection of Epstein-Barr Virus as a Risk Factor for Chronic High Epstein-Barr Viral Load Carriage at a Living-donor-dominant Pediatric Liver Transplantation Center.
Masaki Yamada, Akinari Fukuda, Miyuki Ogura, Seiichi Shimizu, Hajime Uchida, Yuriko Ishikawa

Transplantation· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal-associated invariant T cells are activated in an interleukin-18-dependent manner in Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Yuriko Ishikawa, Masaki Yamada, Naomi Wada, Etsuko Takahashi, Ken-Ichi Imadome

Clin Exp Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Viral Monitoring Study After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Nonmalignant Diseases.
Masaki Yamada, Kenichi Sakamoto, Daisuke Tomizawa, Yuriko Ishikawa, Toshihiro Matsui

Transplant Cell Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypersensitivity to mosquito bites: A versatile Epstein-Barr virus disease with allergy, inflammation, and malignancy.
Masaki Yamada, Yuriko Ishikawa, Ken-Ichi Imadome

Allergol Int· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge.
Xinle Cui, Zhouhong Cao, Yuriko Ishikawa, Sara Cui, Ken-Ichi Imadome

Vaccines (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of AIST-SHANEL Model Based on Spatiotemporally Extensive Monitoring Data of Linear Alkylbenzene Sulfonate in Japan: Toward a Better Strategy on Deriving Predicted Environmental Concentrations.
Tohru Nishioka, Yuichi Iwasaki, Yuriko Ishikawa, Masayuki Yamane, Osamu Morita

Integr Environ Assess Manag· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
Shojiro Haji, Motoaki Shiratsuchi, Takamitsu Matsushima, Akiko Takamatsu, Mariko Tsuda, Yuriko Ishikawa

Int J Hematol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Nucleic acid medicine].
Akira Ishiguro, Yoshikazu Nakamura, Yuriko Ishikawa

Nihon Rinsho· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
Yuriko Ishikawa, Tomohiro Yoshimoto, Kenji Nakanishi

Int Immunol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse.
Takaaki Sugimoto, Yuriko Ishikawa, Tomohiro Yoshimoto, Nobuki Hayashi, Jiro Fujimoto

J Exp Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Tomohiro Yoshimoto, Booki Min, Takaaki Sugimoto, Nobuki Hayashi, Yuriko Ishikawa

J Exp Med· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide.
Kazuhiko Yanagisawa, Ken-ichiro Seino, Yuriko Ishikawa, Mutsumi Nozue, Takeshi Todoroki

J Immunol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis